Literature DB >> 18199464

SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan.

Ling-I Hsu1, Allen W Chiu, Steven K Huan, Chi-Ling Chen, Yuan-Hung Wang, Fang-I Hsieh, Wei-Ling Chou, Li-Hua Wang, Chien-Jen Chen.   

Abstract

A hospital-based case-control study was conducted near a former black-foot disease (BFD)-endemic area in southwestern Taiwan to examine the possible risk factors and genetic susceptibility for urinary transitional cell carcinoma (TCC). A total of 221 patients with pathologically confirmed TCC and 223 age-sex-matched control subjects from urology outpatient clinics were recruited between 1998 and 2002. The results showed that residency in the BFD area and consumption of well water for more than 10 years was a strong factor on urinary cancer risk (odds ratio [OR],8.16, 95% confidence interval [CI],3.34-19.90, p<0.0001). Dose response relationship between average arsenic concentration in well water and TCC risk was also observed. Cigarette smoking played a relatively minor role in urinary carcinogenesis in this study. The GSTP1 Ile105Val A-->G polymorphism was significantly associated with cancer risk (A/G+G/G: OR=0.60, 95%CI=0.39-0.94, p=0.02), and the effect of Val105 allele was largely confined to the subjects diagnosed earlier than 55 years old (A/G+G/G: OR,0.29; 95% CI, 0.09-0.87, p=0.03). The results suggest that GSTP1 is a candidate for susceptibility locus and Ile105 allele may predispose individuals to early-onset urinary TCC. The GSTM1 null genotype was associated with tumors of high-invasiveness (OR,2.21; 95% CI, 1.34-4.73) as well as with early-onset TCC risk (OR,2.53; 95% CI, 0.97-6.59). Our preliminary results showed the XRCC1 Arg194Trp were associated with arsenic-related urinary TCC and the interaction between the genotype and the exposure was statistically significant. The modulating effect of the GSTM1, GSTT1, GSTP1 Ile105Val, EPHX Tyr113His and XRCC1 Arg280His on arsenic-related TCC risk was also suggestive. These observations implied that impaired metabolism of carcinogenic exposure as well as impaired DNA repair function play an important role in arsenic-related urinary transitional cell carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18199464     DOI: 10.1016/j.taap.2007.12.003

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

1.  A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire.

Authors:  Corina Lesseur; Diane Gilbert-Diamond; Angeline S Andrew; Rebecca M Ekstrom; Zhongze Li; Karl T Kelsey; Carmen J Marsit; Margaret R Karagas
Journal:  Toxicol Lett       Date:  2012-01-28       Impact factor: 4.372

2.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

3.  SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer.

Authors:  Margaret R Karagas; Angeline S Andrew; Heather H Nelson; Zhongze Li; Tracy Punshon; Alan Schned; Carmen J Marsit; J Steven Morris; Jason H Moore; Anna L Tyler; Diane Gilbert-Diamond; Mary-Lou Guerinot; Karl T Kelsey
Journal:  Hum Genet       Date:  2011-09-25       Impact factor: 4.132

4.  Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk.

Authors:  Zhenlong Wang; Li Xue; Tie Chong; Hecheng Li; Haiwen Chen; Ziming Wang
Journal:  Tumour Biol       Date:  2013-03-13

5.  XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis.

Authors:  Fei Zhang; Jian-Hong Wu; Wei Zhao; Hai-Tao Liu
Journal:  Tumour Biol       Date:  2013-05-01

6.  GSTM1 and GSTT1 Null Genotype Polymorphisms and Susceptibility to Arsenic Poisoning: a Meta-analysis.

Authors:  Baiming Jin; Siyuan Wan; Michael Boah; Jie Yang; Wenjing Ma; Man Lv; Haonan Li; Kewei Wang
Journal:  Biol Trace Elem Res       Date:  2020-08-08       Impact factor: 3.738

7.  XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis.

Authors:  Zhenqiang Fang; Fanglin Chen; Xiangwei Wang; Shanhong Yi; Wei Chen; Gang Ye
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

8.  Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis.

Authors:  Xiang Li; Zheng Hu; Xinshun Qu; Jiadong Zhu; Lin Li; Brian Z Ring; Li Su
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

9.  Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk.

Authors:  Yeqing Mao; Xin Xu; Yiwei Lin; Hong Chen; Jian Wu; Zhenghui Hu; Yi Zhu; Xianglai Xu; Liping Xie
Journal:  World J Surg Oncol       Date:  2013-03-07       Impact factor: 2.754

Review 10.  Arsenic-induced genotoxicity and genetic susceptibility to arsenic-related pathologies.

Authors:  Francesca Faita; Liliana Cori; Fabrizio Bianchi; Maria Grazia Andreassi
Journal:  Int J Environ Res Public Health       Date:  2013-04-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.